Daily Newsletter

21 November 2023

Daily Newsletter

21 November 2023

BESIX Watpac breaks ground on $90m Eastwood Private Hospital

The hospital will offer a comprehensive range of healthcare options, with a particular focus on reducing surgery waiting times.

November 20 2023

Australia-based construction company BESIX Watpac has broken ground on the $90m Eastwood Private Hospital in Adelaide, reported Glam Adelaide.

The six-storey facility will feature advanced amenities such as a six-theatre perioperative floor, a 51-bed ward, a multi-level car park, a café, retail spaces, and essential medical imaging and pathology services.

This hospital aims to offer a comprehensive range of healthcare options, with a particular focus on reducing surgery waiting times.

The Eastwood Private Hospital project ensures sustainability, targeting a four-Star Green Star rating.

BESIX Watpac’s portfolio includes infrastructure projects for the Department of Defence and the GPO Hotel Marriott, as well as the expansion and refurbishment of Adelaide Airport's terminal.

BESIX Watpac CEO Mark Baker was quoted by the news website as saying: “Our extensive expertise, collaborative approach and knowledge of the technical and services requirements of health and sciences infrastructure will contribute significantly to the successful delivery of this project.”

“We are pleased to include Eastwood Private Hospital as one of the 11 major health infrastructure projects currently being undertaken by BESIX Watpac across Australia.”

In August 2023, BESIX Watpac completed construction on the new hospital wing of the St John of God Ballarat Hospital redevelopment project.

St John of God Ballarat Hospital in Victoria, Australia is undergoing a redevelopment project that involves the establishment of a new medical services building at the front of the hospital.

The project includes the creation of a new 10-bed ICU/CCU, a Central Sterile Services Department (CSSD), four operating theatres, and a 30-bed in-patient ward.

This redevelopment aims to meet the healthcare needs of the growing Ballarat and surrounding regions, providing residents with quality healthcare locally.

The project is slated for completion in the second quarter of 2024.

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close